ProAssurance在获得宾夕法尼亚州批准出售给Doctors后收益

2026-06-03 23:05

ProAssurance (PRO) rose 2% after the company announced that it received approval from Pennsylvania's insurance regulator for its planned sale to Doctors Company.
ProAssurance (PRO) is still awaiting approval from the California insurance regulator, according to an 8-K filing on Tuesday. The company reiterated that it expects to close the transaction by June 30.
Last March, The Doctors Company agreed to purchase PRA in a deal valued at $1.3B or $25 a share in cash.

More on ProAssurance